Search research articles
Contact Us
Filters
Showing results (41-50 of 92) with videos related to
Page
of 10
Sort By:
Annals of Botany
|
September 15, 2005
Palynological variation in Balsaminoid Ericales. II. Balsaminaceae, Tetrameristaceae, Pellicieraceae and general conclusions
Steven Janssens, Frederic Lens, Stefan Dressler, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
March 1, 2011
Pharmacoeconomics of darunavir
Dwight S Fullerton, Erik Smets, Guy De La Rosa, et al.
Journal of Experimental Botany
|
June 8, 2004
Changes in pit membrane porosity due to deflection and stretching: the role of vestured pits
Brendan Choat, Steven Jansen, Maciej A Zwieniecki, et al.
HIV Clinical Trials
|
August 26, 2010
Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States
Anita J Brogan, Joseph Mrus, Andrew Hill, et al.
The New Phytologist
|
April 20, 2021
Intervascular pit membranes with a torus in the wood of Ulmus (Ulmaceae) and related genera
Steven Jansen, Brendan Choat, Stefan Vinckier, et al.
Tree Physiology
|
August 13, 2013
The evolution and function of vessel and pit characters with respect to cavitation resistance across 10 Prunus species
Alexander Scholz, David Rabaey, Anke Stein, et al.
Plos One
|
July 17, 2019
Is the bacterial leaf nodule symbiosis obligate for Psychotria umbellata? The development of a Burkholderia-free host plant
Arne Sinnesael, Olivier Leroux, Steven B Janssens, et al.
Molecular Phylogenetics and Evolution
|
January 27, 2007
Phylogenetic utility of the AP3/DEF K-domain and its molecular evolution in Impatiens (Balsaminaceae)
Steven Janssens, Koen Geuten, Tom Viaene, et al.
Annals of Botany
|
March 4, 2010
Spikelet structure and development in Cyperoideae (Cyperaceae): a monopodial general model based on ontogenetic evidence
Alexander Vrijdaghs, Marc Reynders, Isabel Larridon, et al.
Pharmacoeconomics
|
December 25, 2010
Costs to achieve undetectable HIV RNA with darunavir-containing highly active antiretroviral therapy in highly pretreated patients: the POWER experience
Andrew M Hill, Bonaventura Clotet, Margaret Johnson, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 92) with videos related to
Sort By:
Page
of 10
Annals of Botany
|
September 15, 2005
Palynological variation in Balsaminoid Ericales. II. Balsaminaceae, Tetrameristaceae, Pellicieraceae and general conclusions
Steven Janssens, Frederic Lens, Stefan Dressler, et al.
Expert Review of Pharmacoeconomics & Outcomes Research
|
March 1, 2011
Pharmacoeconomics of darunavir
Dwight S Fullerton, Erik Smets, Guy De La Rosa, et al.
Journal of Experimental Botany
|
June 8, 2004
Changes in pit membrane porosity due to deflection and stretching: the role of vestured pits
Brendan Choat, Steven Jansen, Maciej A Zwieniecki, et al.
HIV Clinical Trials
|
August 26, 2010
Comparative cost-efficacy analysis of darunavir/ritonavir and other ritonavir-boosted protease inhibitors for first-line treatment of HIV-1 infection in the United States
Anita J Brogan, Joseph Mrus, Andrew Hill, et al.
The New Phytologist
|
April 20, 2021
Intervascular pit membranes with a torus in the wood of Ulmus (Ulmaceae) and related genera
Steven Jansen, Brendan Choat, Stefan Vinckier, et al.
Tree Physiology
|
August 13, 2013
The evolution and function of vessel and pit characters with respect to cavitation resistance across 10 Prunus species
Alexander Scholz, David Rabaey, Anke Stein, et al.
Plos One
|
July 17, 2019
Is the bacterial leaf nodule symbiosis obligate for Psychotria umbellata? The development of a Burkholderia-free host plant
Arne Sinnesael, Olivier Leroux, Steven B Janssens, et al.
Molecular Phylogenetics and Evolution
|
January 27, 2007
Phylogenetic utility of the AP3/DEF K-domain and its molecular evolution in Impatiens (Balsaminaceae)
Steven Janssens, Koen Geuten, Tom Viaene, et al.
Annals of Botany
|
March 4, 2010
Spikelet structure and development in Cyperoideae (Cyperaceae): a monopodial general model based on ontogenetic evidence
Alexander Vrijdaghs, Marc Reynders, Isabel Larridon, et al.
Pharmacoeconomics
|
December 25, 2010
Costs to achieve undetectable HIV RNA with darunavir-containing highly active antiretroviral therapy in highly pretreated patients: the POWER experience
Andrew M Hill, Bonaventura Clotet, Margaret Johnson, et al.
Page
of 10